B. Veber et Jj. Pocidalo, PARTICULAR CASE OF AZALIDES - ANTIBIOTIC DIAPEDESIS MEDIATE BY POLYNUCLEAR CELLS, EXPERIMENTAL-DATA FROM PNEUMOCOCCAL PNEUMONIA MURINE MODEL, Pathologie et biologie, 43(6), 1995, pp. 524-528
The relations between the clinical efficacy, phagocytic transport phen
omena, tissular and sera kinetics have been assessed in a pneumonia mu
rine model. At first, the correlation between the clinical efficacy an
d pharmacokinetics characteristics has been studied for the erythromyc
in, spiramycin, roxithromycin, clarithromycin and azithromycin. An in
vivo clinical efficacy hierarchy has been established (azi > ery > rox
i = azi > spiral. A hierarchy identical to the clinical efficacy, has
been recognised for the pulmonary elimination half lives and the pulmo
nar AUC. These could be considered as predictive of these antibiotics
activity in the respiratory infections. In a second time, the tissular
pharmacokinetics of the azithromycin in leukopenic mice allowed to co
nfirm the leukocytes role in the transport and release of this antibio
tic in the midst of the infections site. Finally, this antibiotic demo
nstrated its efficacy in a bacterienic infection even when administere
d at a low dosage thus allowing to have sera concentrations identical
to those obtained in human clinical case and close to MIC's for S. pne
umoniae. The pharmacokinetic novelty displayed by its strong tissular
penetration can explain its remarkable efficacy.